Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Somerset Therapeutics, LLC, priced at $3.1575 per ML under NDC 70069065101. Its NADAC has been published 80 times since May 7, 2025.

FDA first approved this application on Sep 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$3.1575per ML

Strength

2; 5 mg/mL; mg/mL

NDC

70069065101

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216114

FDA Approved

9/10/2024

TE Code

AB

On Market Since

10/10/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 80 times since May 7, 2025, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.

Current price$3.1575 per ML
All-time high$6.6603 (May 14, 2025)
All-time low$2.7175 (Sep 23, 2026)
52-week high$3.8840
52-week low$2.7175
Median price$3.4098
Average price$3.8517
Largest weekly change+16.2% (Oct 21, 2026)
Weeks tracked80
Tracking sinceMay 7, 2025

Price History

1W

0.0%

1M

+16.2%

3M

+11.3%

6M

-1.2%

1Y

-17.1%

3Y

N/A

5Y

N/A

All

-52.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Somerset Therapeutics, LLC, is $3.1575 per ML (NDC 70069065101), effective Nov 11, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 52.6%. It has been tracked across 80 weekly CMS publications since May 7, 2025.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since May 7, 2025, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $2.7175 (Sep 23, 2026) to a high of $6.6603 (May 14, 2025), with a median of $3.4098 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $1.9993 per ML — about 37% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 70069065101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.